The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis
Open accessAbstract
There are two distinct subtypes of multiple sclerosis in Asians, opticospinal (OS-multiple sclerosis) and conventional (C-multiple sclerosis). In OS-multiple sclerosis, selective and severe involvement of the optic nerves and spinal cord is characteristic, though its mechanisms are unknown. The present study aimed to find out possible differences in the cytokine/chemokine profiles in CSF between OS-multiple sclerosis and C-multiple sclerosis and to delineate the relationships between these profiles and neuroimaging and pathological features. Sixteen cytokines/chemokines, namely interleukin (IL)-1beta, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12 (p70), IL-13, IL-17, interferon (IFN)-gamma, tumour necrosis factor (TNF)-alpha, granulocyte colony-stimulating factor (G-CSF), monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1beta (MIP-1beta), were measured simultaneously in CSF supernatants from 40 patients with relapsing-remitting multiple sclerosis (20 OS-multiple sclerosis and 20 C-multiple sclerosis) at relapse and 19 control patients with spinocerebellar degeneration (SCD), together with intracellular production of IFN-gamma and IL-4 in CSF CD4+ T cells. In CSF supernatants relative to controls, IL-17, MIP-1beta, IL-1beta and IL-13 were only significantly increased in OS-multiple sclerosis patients, while TNF-alpha was only significantly increased in C-multiple sclerosis patients, using a cut-off level of 1 pg/ml. IL-8 was significantly elevated in both OS-multiple sclerosis and C-multiple sclerosis patients. MCP-1 was significantly decreased in both OS-multiple sclerosis and C-multiple sclerosis patients, while IL-7 was only significantly decreased in C-multiple sclerosis patients. IL-17, IL-8 and IL-5 were significantly higher in OS-multiple sclerosis patients than in C-multiple sclerosis patients. The increases in IL-17 and IL-8 in OS-multiple sclerosis were still significant even after exclusion of the patients undergoing various immunomodulatory therapies. Assays of intracellular cytokine production revealed that both the IFN-gamma+IL-4- T-cell percentage and intracellular IFN-gamma/IL-4 ratio in CSF cells were significantly greater in C-multiple sclerosis patients than in controls. Contrarily, OS-multiple sclerosis patients showed not only a significantly greater percentage of IFN-gamma+IL-4- T cells than controls but also a significantly higher percentage of IFN-gamma-IL-4+ T cells than C-multiple sclerosis patients. Among the cytokines elevated in multiple sclerosis, only IL-8 showed a significant positive correlation with the Expanded Disability Status Scale of Kurtzke score. Both the length of the spinal cord lesions on MRI and the CSF/serum albumin ratio had a significant positive correlation with IL-8 and IL-17 in multiple sclerosis, in which the spinal cord lesions were significantly longer in OS-multiple sclerosis than in C-multiple sclerosis. Three of six spinal cord specimens from autopsied OS-multiple sclerosis cases demonstrated numerous myeloperoxidase-positive neutrophils infiltrating necrotic lesions. These findings strongly suggest that in OS-multiple sclerosis, in addition to the Th1 cell upregulation seen in C-multiple sclerosis, intrathecal activation of the IL-17/IL-8 axis inducing heavy neutrophil infiltration contributes to extensive spinal cord lesion formation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
Kurtzke, J. F. (1983) · Neurology · doi:10.1212/wnl.33.11.1444 · Cited by 15,011
McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H., Lublin, F. D., McFarland, H. F., Paty, D. W., Polman, C. H., Reingold, S. C., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1032 · Cited by 6,969
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
Lennon, V. A., Wingerchuk, D. M., Kryzer, T. J., Pittock, S. J., Lucchinetti, C. F., Fujihara, K., Nakashima, I., & Weinshenker, B. G. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17551-x · Cited by 3,239
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906
Aggarwal, S., Ghilardi, N., Xie, M.-H., de Sauvage, F. J., & Gurney, A. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207577200 · Cited by 1,847
The clinical course of neuromyelitis optica (Devic’s syndrome)
Wingerchuk, D. M., Hogancamp, W. F., O’Brien, P. C., & Weinshenker, B. G. (1999) · Neurology · doi:10.1212/wnl.53.5.1107 · Cited by 1,822
Kotake, S., Udagawa, N., Takahashi, N., Matsuzaki, K., Itoh, K., Ishiyama, S., Saito, S., Inoue, K., Kamatani, N., Gillespie, M. T., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5703 · Cited by 1,696
Lock, C., Hermans, G., Pedotti, R., Brendolan, A., Schadt, E., Garren, H., Langer-Gould, A., Strober, S., Cannella, B., Allard, J., et al. (2002) · Nature Medicine · doi:10.1038/nm0502-500 · Cited by 1,669
T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines
Fossiez, F., Djossou, O., Chomarat, P., Flores-Romo, L., Ait-Yahia, S., Maat, C., Pin, J. J., Garrone, P., Garcia, E., Saeland, S., et al. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.6.2593 · Cited by 1,526 · cited 2×
“IL-17 is produced by activated memory Th1 cells (Aarvak et al., 1999) and induces various downstream cytokines and chemokines, such as IL-8, IL-6, G-CSF and prostaglandin E2 (Fossiez et al., 1996; Dudler et al., 2000; Hwang et al., 2004).”
BackgroundA role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica
Lucchinetti, C. F. (2002) · Brain · doi:10.1093/brain/awf151 · Cited by 1,210
Exacerbations of multiple sclerosis in patients treated with gamma interferon
Panitch, H., Haley, A., Hirsch, R., & Johnson, K. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92863-7 · Cited by 1,071
Multiple control of interleukin-8 gene expression
Hoffmann, E., Dittrich-Breiholz, O., Holtmann, H., & Kracht, M. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.72.5.847 · Cited by 1,058
Sørensen, T. L., Tani, M., Jensen, J., Pierce, V., Lucchinetti, C., Folcik, V. A., Qin, S., Rottman, J., Sellebjerg, F., Strieter, R. M., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5150 · Cited by 1,002
IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines
Molet, S., Hamid, Q., Davoineb, F., Nutku, E., Tahaa, R., Pagé, N., Olivenstein, R., Elias, J., & Chakir, J. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.117929 · Cited by 953
Multiplexed particle-based flow cytometric assays
Vignali, D. A. A. (2000) · Journal of Immunological Methods · doi:10.1016/s0022-1759(00)00238-6 · Cited by 913
Neutrophil Recruitment by Human IL-17 Via C-X-C Chemokine Release in the Airways
Laan, M., Cui, Z.-H., Hoshino, H., Lötvall, J., Sjöstrand, M., Gruenert, D. C., Skoogh, B.-E., & Lindén, A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.4.2347 · Cited by 880
Sharief, M. K., & Hentges, R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199108153250704 · Cited by 809
Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis
Matusevicius, D., Kivisäkk, P., He, B., Kostulas, N., Özenci, V, Fredrikson, S., & Link, H. (1999) · Multiple Sclerosis Journal · doi:10.1177/135245859900500206 · Cited by 751
Ziolkowska, M., Koc, A., Luszczykiewicz, G., Ksiezopolska-Pietrzak, K., Klimczak, E., Chwalinska-Sadowska, H., & Maslinski, W. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.5.2832 · Cited by 580
de Jager, W., te Velthuis, H., Prakken, B. J., Kuis, W., & Rijkers, G. T. (2003) · Clinical and Vaccine Immunology · doi:10.1128/cdli.10.1.133-139.2003 · Cited by 568
Storch, M. K., Stefferl, A., Brehm, U., Weissert, R., Wallström, E., Kerschensteiner, M., Olsson, T., Linington, C., & Lassmann, H. (1998) · Brain Pathology · doi:10.1111/j.1750-3639.1998.tb00194.x · Cited by 522
Lafaille, J. J., Keere, F. V. D., Hsu, A. L., Baron, J. L., Haas, W., Raine, C. S., & Tonegawa, S. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.2.307 · Cited by 426
Multiple sclerosis in the Japanese population
Kira, J.-I. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00308-9 · Cited by 419
Self-citationIL-17 Is Produced by Some Proinflammatory Th1/Th0 Cells But Not by Th2 Cells
Aarvak, T., Chabaud, M., Miossec, P., & Natvig, J. B. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.3.1246 · Cited by 410
Hwang, S.-Y., Kim, J.-Y., Kim, K.-W., Park, M.-K., Moon, Y., Kim, W.-U., & Kim, H.-Y. (2004) · Arthritis Res Ther · doi:10.1186/ar1038 · Cited by 404
Review: cytokines and the pathogenesis of multiple sclerosis
Navikas, V., & Link, H. (1996) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19960815)45:4<322::aid-jnr1>3.0.co;2-b · Cited by 328
Yamasaki, K., Kira, J., Kawano, Y., Kobayashi, T., Kanai, T., Nishimura, Y., Matsushita, S., Hasuo, K., & Tobimatsu, S. (1996) · Annals of Neurology · doi:10.1002/ana.410400405 · Cited by 302
Self-citationMiyamoto, M., Prause, O., Sjöstrand, M., Laan, M., Lötvall, J., & Lindén, A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.9.4665 · Cited by 281
Van Boxel-Dezaire, A. H. H., Hoff, S. C. J., Van Oosten, B. W., Verweij, C. L., Dräger, A. M., Adèr, H. J., Van Houwelingen, J. C., Barkhof, F., Polman, C. H., & Nagelkerken, L. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199906)45:6<695::aid-ana3>3.0.co;2-r · Cited by 265
Miossec, P. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10816 · Cited by 264
Sørensen, T. L., Trebst, C., Kivisäkk, P., Klaege, K. L., Majmudar, A., Ravid, R., Lassmann, H., Olsen, D. B., Strieter, R. M., Ransohoff, R. M., et al. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00097-8 · Cited by 263
Interleukin-17: a mediator of inflammatory responses
Witowski, J., Książek, K., & Jörres, A. (2004) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/s00018-003-3228-z · Cited by 245
OLSSON, T. (1995) · Immunological Reviews · doi:10.1111/j.1600-065x.1995.tb00072.x · Cited by 232
Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis
Rieckmann, P., Albrecht, M., Kitze, B., Weber, T., Tumani, H., Broocks, A., Lüer, W., & Poser, S. (1994) · Neurology · doi:10.1212/wnl.44.8.1523 · Cited by 225
The CD4–Th1 model for multiple sclerosis: a crucial re-appraisal
Lassmann, H., & Ransohoff, R. M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.01.007 · Cited by 203
Kellar, K. L., Kalwar, R. R., Dubois, K. A., Crouse, D., Chafin, W. D., & Kane, B.-E. (2001) · Cytometry · doi:10.1002/1097-0320(20010901)45:1<27::aid-cyto1141>3.0.co;2-i · Cited by 194
Yamasaki, K. (1999) · Brain · doi:10.1093/brain/122.9.1689 · Cited by 180
Franciotta, D., Martino, G., Zardini, E., Furlan, R., Bergamaschi, R., Andreoni, L., & Cosi, V. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00261-2 · Cited by 174
Becher, B., Durell, B. G., & Noelle, R. J. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319079 · Cited by 173
Stürzebecher, S., Wandinger, K. P., Rosenwald, A., Sathyamoorthy, M., Tzou, A., Mattar, P., Frank, J. A., Staudt, L., Martin, R., & McFarland, H. F. (2003) · Brain · doi:10.1093/brain/awg147 · Cited by 168
Becher, B., Durell, B. G., & Noelle, R. J. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19079 · Cited by 165
The cytokine storm in multiple sclerosis
Link, H. (1998) · Multiple Sclerosis Journal · doi:10.1177/135245859800400104 · Cited by 163
Increased transforming growth factor‐β, interleukin‐4, and interferon‐γ in multiple sclerosis
Link, J., Söderström, M., Olsson, T., Höjeberg, B., Ljungdahl, Å., & Link, H. (1994) · Annals of Neurology · doi:10.1002/ana.410360309 · Cited by 162
Role of Interleukin-17 and the Neutrophil in Asthma
Lindén, A. (2001) · International Archives of Allergy and Immunology · doi:10.1159/000049511 · Cited by 158
Stefferl, A., Brehm, U., Storch, M. K., Lambracht‐Washington, D., Bourquin, C., Wonigeit, K., Lassmann, H., & Linington, C. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.1.40 · Cited by 155
Mahad, D., Howell, S. J., & Woodroofe, M. N. (2002) · PubMed · doi:10.1136/jnnp.72.4.498 · Cited by 154
Pathogenesis of multiple sclerosis: an update on immunology
Hemmer, B., Cepok, S., Nessler, S., & Sommer, N. (2002) · Current Opinion in Neurology · doi:10.1097/00019052-200206000-00001 · Cited by 139
Hoshino, H., Laan, M., Sjöstrand, M., Lötvall, J. O., Skoogh, B., & Lindén, A. (2000) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(00)90189-1 · Cited by 138
Cree, B., Goodin, D. S., & Hauser, S. L. (2002) · Seminars in Neurology · doi:10.1055/s-2002-36534 · Cited by 135
Trebst, C., & Ransohoff, R. M. (2001) · Archives of Neurology · doi:10.1001/archneur.58.12.1975 · Cited by 115
Scarpini, E. A., Galimberti, D., Baron, P., Clerici, R., Ronzoni, M., Conti, G. M., & Scarlato, G. (2002) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(01)00680-3 · Cited by 110
Niino, M., Ogata, A., Kikuchi, S., Tashiro, K., & Nishihira, J. (2000) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(00)00397-x · Cited by 109
Navikas, V., He, B., Link, J., Haglund, M., Söderström, M. B., Fredrikson, S., Ljungdahl, Å., Höjeberg, B., Qiao, J., Olsson, T. P., et al. (1996) · Brain · doi:10.1093/brain/119.1.213 · Cited by 98
Increased release of interleukin-12p40 in MS
Fassbender, K. C., Ragoschke, A., Rossol, S., Schwartz, A., Mielke, O., Paulig, A., & Hennerici, M. G. (1998) · Neurology · doi:10.1212/wnl.51.3.753 · Cited by 89
Neutrophilic airway inflammation and IL‐17
Lindén, A., & Adachi, M. (2002) · Allergy · doi:10.1034/j.1398-9995.2002.02164.x · Cited by 85
Effect of interleukin 17 on proteoglycan degradation in murine knee joints
Dudler, J., Renggli-Zulliger, N., Busso, N., Lotz, M., & So, A. (2000) · Annals of the Rheumatic Diseases · doi:10.1136/ard.59.7.529 · Cited by 78
Matusevičius, D., Navikas, V., Söderström, M. B., Xiao, B., Haglund, M., Fredrikson, S., & Link, H. (1996) · Journal of Neuroimmunology · doi:10.1016/0165-5728(96)00032-x · Cited by 68
Sharief, M. K., & Thompson, E. J. (1993) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.56.2.169 · Cited by 55
Ochi, H., Wu, X.-M., Osoegawa, M., Horiuchi, I., Minohara, M., Murai, H., Ohyagi, Y., Furuya, H., & Kira, J.-I. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00393-9 · Cited by 54
Self-citationInterferon-β treatment alters peripheral blood monocytes chemokine production in MS patients
Comabella, M., Imitola, J., Weiner, H. L., & Khoury, S. J. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00064-4 · Cited by 50
Drulovic, J. S., Mostarica‐Stojković, M., Lević, Z., Stojsavljević, N., Pravica, V., & Mesaroš, Š. (1997) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(96)05320-8 · Cited by 50
Horiuchi, I., Kawano, Y., Yamasaki, K., Minohara, M., Furue, M., Taniwaki, T., Miyazaki, T., & Kira, J. (2000) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00232-4 · Cited by 48
Self-citationHuang, W., Huang, P., Link, H., & Hillert, J. A. (1999) · Multiple Sclerosis Journal · doi:10.1177/135245859900500507 · Cited by 46
Allergic Encephalomyelitis in Common Marmosets: Pathogenesis of a Multiple Sclerosis-like Lesion
Genain, C. P., & Hauser, S. L. (1996) · Methods · doi:10.1006/meth.1996.0120 · Cited by 41
Wu, X.-M., Osoegawa, M., Yamasaki, K., Kawano, Y., Ochi, H., Horiuchi, I., Minohara, M., Ohyagi, Y., Yamada, T., & Kira, J. (2000) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(00)00322-1 · Cited by 38
Self-citationDifferential intracellular expression of CCR5 and chemokines in multiple sclerosis subtypes
Jalonen, T. O., Pulkkinen, K. H., Ukkonen, M., Saarela, M., & Elovaara, I. (2002) · Journal of Neurology · doi:10.1007/s004150200067 · Cited by 35
Kleine, T. O., Zwerenz, P., Graser, C., & Zöfel, P. (2003) · Brain Research Bulletin · doi:10.1016/s0361-9230(03)00096-0 · Cited by 31
Minohara, M., Ochi, H., Matsushita, S., Irie, A., Nishimura, Y., & Kira, J. (2001) · Tissue Antigens · doi:10.1034/j.1399-0039.2001.057005447.x · Cited by 28
Self-citation
Cited by
Korn, T., Bettelli, E., Oukka, M., & Kuchroo, V. K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132710 · Cited by 4,873
Interleukin-17 and Type 17 Helper T Cells
Miossec, P., Korn, T., & Kuchroo, V. K. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0707449 · Cited by 1,409
Tzartos, J. S., Friese, M. A., Craner, M. J., Palace, J., Newcombe, J., Esiri, M. M., & Fugger, L. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.070690 · Cited by 1,187
Tesmer, L. A., Lundy, S. K., Sarkar, S., & Fox, D. A. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00628.x · Cited by 1,102
Kroenke, M. A., Carlson, T. J., Andjelkovic, A. V., & Segal, B. M. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080159 · Cited by 579
Metadata
- Authors
- Ishizu, T., Osoegawa, M., Mei, F.-J., Kikuchi, H., Tanaka, M., Takakura, Y., Minohara, M., Murai, H., Mihara, F., Taniwaki, T., & Kira, J.-I.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-03-02
- Volume
- 128
- Issue
- 5
- Pages
- 988-1002
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2124376257
- Cited by
- 334
- References
- 68
- FWCI
- 11.35
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.